BR112020018025A2 - Comprimido farmacêutico sólido para administração oral e método de liberação de carbonato de cálcio a partir de um comprimido farmacêutico sólido - Google Patents

Comprimido farmacêutico sólido para administração oral e método de liberação de carbonato de cálcio a partir de um comprimido farmacêutico sólido Download PDF

Info

Publication number
BR112020018025A2
BR112020018025A2 BR112020018025-4A BR112020018025A BR112020018025A2 BR 112020018025 A2 BR112020018025 A2 BR 112020018025A2 BR 112020018025 A BR112020018025 A BR 112020018025A BR 112020018025 A2 BR112020018025 A2 BR 112020018025A2
Authority
BR
Brazil
Prior art keywords
tablet
calcium carbonate
weight
chewing
amount
Prior art date
Application number
BR112020018025-4A
Other languages
English (en)
Portuguese (pt)
Inventor
Jesper Neergaard
Original Assignee
Fertin Pharma A/S
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fertin Pharma A/S filed Critical Fertin Pharma A/S
Publication of BR112020018025A2 publication Critical patent/BR112020018025A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A61K9/0058—Chewing gums
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A61K33/10—Carbonates; Bicarbonates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Inorganic Chemistry (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Pain & Pain Management (AREA)
  • Zoology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
BR112020018025-4A 2018-03-23 2019-03-21 Comprimido farmacêutico sólido para administração oral e método de liberação de carbonato de cálcio a partir de um comprimido farmacêutico sólido BR112020018025A2 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US15/933,942 2018-03-23
US15/933,942 US10980831B2 (en) 2018-03-23 2018-03-23 Solid pharmaceutical tablet
PCT/DK2019/050100 WO2019179589A1 (en) 2018-03-23 2019-03-21 A solid pharmaceutical tablet

Publications (1)

Publication Number Publication Date
BR112020018025A2 true BR112020018025A2 (pt) 2020-12-22

Family

ID=65995450

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112020018025-4A BR112020018025A2 (pt) 2018-03-23 2019-03-21 Comprimido farmacêutico sólido para administração oral e método de liberação de carbonato de cálcio a partir de um comprimido farmacêutico sólido

Country Status (10)

Country Link
US (3) US10980831B2 (https=)
EP (2) EP3768248B1 (https=)
JP (1) JP7303211B2 (https=)
CN (1) CN111902135A (https=)
AU (2) AU2019239514B2 (https=)
BR (1) BR112020018025A2 (https=)
CA (1) CA3094737A1 (https=)
ES (1) ES2951267T3 (https=)
PL (1) PL3768248T3 (https=)
WO (1) WO2019179589A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2025230986A1 (en) * 2024-04-29 2025-11-06 Anju Majeed Aqueous dispersion of molecules-process, formulation and method thereof

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4327076A (en) * 1980-11-17 1982-04-27 Life Savers, Inc. Compressed chewable antacid tablet and method for forming same
US4753805A (en) 1984-01-31 1988-06-28 Warner-Lambert Company Tabletted chewing gum composition and method of preparation
ZA87994B (en) 1986-02-27 1987-09-30 Warner Lambert Co Antacid chewing gum
JPH0695888B2 (ja) * 1989-10-18 1994-11-30 株式会社サンギ カルシウム補給用チューインガム
US5637313A (en) 1994-12-16 1997-06-10 Watson Laboratories, Inc. Chewable dosage forms
EP1173154A4 (en) * 1999-04-15 2003-07-23 Wrigley W M Jun Co CHEWING GUM FOR DENTAL CARE, WHICH CONTAINS CALCIUM IN A PLEASANT ACID
US7244455B2 (en) 2002-01-16 2007-07-17 Warner-Lambert Company Center-filled chewing gum containing a deliverable form of calcium
EP1495680A1 (en) 2003-07-08 2005-01-12 Gum Base Co. S.p.A. Gum base for chewing gum
WO2006000233A1 (en) * 2004-06-29 2006-01-05 Fertin Pharma A/S Tobacco alkaloid containing chewing gum
DK1765304T4 (da) * 2004-07-06 2019-06-03 Fertin Pharma As Komprimattyggegummitablet
US8765178B2 (en) 2006-07-19 2014-07-01 Watson Laboratories, Inc. Controlled release formulations and associated methods
MX2009008997A (es) 2007-02-26 2010-01-20 Revolymer Ltd Goma de mascar medicada.
WO2015070875A1 (en) 2013-11-15 2015-05-21 Fertin Pharma A/S Chewing gum suitable for diabetics
US10426726B2 (en) 2014-04-08 2019-10-01 Fertin Pharma A/S Medical chewing gum
GB2542192A (en) * 2015-09-11 2017-03-15 Revolymer (Uk) Ltd Chewable medicament
CA3000770A1 (en) 2015-10-07 2017-04-13 Fertin Pharma A/S Chewing gum comprising nicotine
ITUA20163230A1 (it) * 2016-05-06 2017-11-06 Perfetti Van Melle Spa Gomma da masticare con stevia
US10933017B2 (en) 2019-03-01 2021-03-02 Nordiccan A/S Tableted cannabinoid chewing gum with polyvinyl acetate elastomer plasticizers

Also Published As

Publication number Publication date
AU2019239514A1 (en) 2020-10-29
EP3831368A1 (en) 2021-06-09
EP3768248C0 (en) 2023-06-14
EP3768248B1 (en) 2023-06-14
US20190290684A1 (en) 2019-09-26
PL3768248T3 (pl) 2023-08-28
CA3094737A1 (en) 2019-09-26
ES2951267T3 (es) 2023-10-19
US11730757B2 (en) 2023-08-22
CN111902135A (zh) 2020-11-06
EP3768248A1 (en) 2021-01-27
AU2019239514B2 (en) 2024-02-01
WO2019179589A1 (en) 2019-09-26
JP2021518412A (ja) 2021-08-02
US11723918B2 (en) 2023-08-15
US20210023128A1 (en) 2021-01-28
AU2024202892B2 (en) 2025-01-16
US20210205355A1 (en) 2021-07-08
JP7303211B2 (ja) 2023-07-04
AU2024202892A1 (en) 2024-05-23
US10980831B2 (en) 2021-04-20

Similar Documents

Publication Publication Date Title
CN106456560B (zh) 医用口香糖
CN101035437B (zh) 糖果产品
JP7214755B2 (ja) 医薬品活性成分に適した錠剤化チューインガム
US6949264B1 (en) Nutraceuticals or nutritional supplements and method of making
KR101168348B1 (ko) 압착된 츄잉 검 정제
US6627234B1 (en) Method of producing active agent coated chewing gum products
CA2589489C (en) Method of providing fast relief to a user of a nicotine chewing gum
US20090304824A1 (en) Rapid-Melt Compositions, Methods of Making Same and Methods of Using Same
US6569472B1 (en) Coated chewing gum products containing antacid and method of making
US6541048B2 (en) Coated chewing gum products containing an acid blocker and process of preparing
BRPI0413098B1 (pt) Base para goma de mascar e composições de goma de mascar
AU2024202892B2 (en) A solid pharmaceutical tablet
US6663849B1 (en) Antacid chewing gum products coated with high viscosity materials
ES2352147T3 (es) Goma de mascar que comprende polietileno.
WO2017042592A1 (en) Chewable medicament
CA2355779C (en) Improved release of medicament active agents from a chewing gum coating
Badola Medicated Chewing gums a novel oral drug delivery method: A review
JP2010252816A (ja) 圧縮チューインガムタブレット
RU2347367C1 (ru) Кондитерский продукт
BR112019008138B1 (pt) Comprimido de fornecimento oral que compreende agente aglutinante e eritritol separados
Daharwal et al. Chewing Gum as Novel Approach for Delivery of Medicament: A Review
JUNO et al. PHARMACEUTICAL SCIENCES
JP2014158484A (ja) 圧縮チューインガムタブレット

Legal Events

Date Code Title Description
B350 Update of information on the portal [chapter 15.35 patent gazette]
B06W Patent application suspended after preliminary examination (for patents with searches from other patent authorities) chapter 6.23 patent gazette]